Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Newell

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Pediatric Diabetes|February 9, 2018
Whole-exome sequencing for mutation detection in pediatric disorders of insulin secretion: Maturity onset diabetes of the young and congenital hyperinsulinismS R Johnson, P J Leo, A M McInerney-Leo, et al.
Cytotherapy|February 20, 2026
Impact of ABO compatibility on outcomes after allogeneic hematopoietic cell transplantation (HCT): increased risk of acute GVHD with ABO bidirectional mismatch, independent of traditional and emerging GVHD prophylaxis strategiesYun Yu, Mikayla K Murphy, Virginia Tan, et al.
Cancers|March 13, 2024
CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 TrialScott R Solomon, Bayard L Powell, Jamie Koprivnikar, et al.
Bone Marrow Transplantation|June 6, 2017
Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402S G Holtan, L F Newell, C Cutler, et al.
RSC Medicinal Chemistry|August 3, 2022
<i>De novo</i> design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding regionKyle M Orritt, Lipeng Feng, Juliette F Newell, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2019
A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemiasTara L Lin, Laura F Newell, Robert K Stuart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2019
Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell TransplantationLaura F Newell, Todd E DeFor, Corey Cutler, et al.
BMC Hematology|September 16, 2014
Impact of clinical factors and allograft leukocyte content on post-transplant lymphopenia, monocytopenia, and survival in patients undergoing allogeneic peripheral blood haematopoietic cell transplantMary D Thoma, Jennifer Glejf, Eapen Jacob, et al.
Cytotherapy|May 16, 2019
Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donorsLaura F Newell, Kelsea M Shoop, Rebekah J Knight, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 12, 2015
Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802Shernan G Holtan, Michael R Verneris, Kirk R Schultz, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Pediatric Diabetes|February 9, 2018
Whole-exome sequencing for mutation detection in pediatric disorders of insulin secretion: Maturity onset diabetes of the young and congenital hyperinsulinismS R Johnson, P J Leo, A M McInerney-Leo, et al.
Cytotherapy|February 20, 2026
Impact of ABO compatibility on outcomes after allogeneic hematopoietic cell transplantation (HCT): increased risk of acute GVHD with ABO bidirectional mismatch, independent of traditional and emerging GVHD prophylaxis strategiesYun Yu, Mikayla K Murphy, Virginia Tan, et al.
Cancers|March 13, 2024
CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 TrialScott R Solomon, Bayard L Powell, Jamie Koprivnikar, et al.
Bone Marrow Transplantation|June 6, 2017
Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402S G Holtan, L F Newell, C Cutler, et al.
RSC Medicinal Chemistry|August 3, 2022
<i>De novo</i> design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding regionKyle M Orritt, Lipeng Feng, Juliette F Newell, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2019
A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemiasTara L Lin, Laura F Newell, Robert K Stuart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2019
Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell TransplantationLaura F Newell, Todd E DeFor, Corey Cutler, et al.
BMC Hematology|September 16, 2014
Impact of clinical factors and allograft leukocyte content on post-transplant lymphopenia, monocytopenia, and survival in patients undergoing allogeneic peripheral blood haematopoietic cell transplantMary D Thoma, Jennifer Glejf, Eapen Jacob, et al.
Cytotherapy|May 16, 2019
Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donorsLaura F Newell, Kelsea M Shoop, Rebekah J Knight, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 12, 2015
Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802Shernan G Holtan, Michael R Verneris, Kirk R Schultz, et al.
Pageof 7